Gary Kobinger, PhD, is the Director of the Galveston National
Laboratory, one of the largest active biocontainment facilities on an
academic campus. Dr. Kobinger has co-authored over 300 peer-reviewed
scientific manuscripts and accumulated more than 20 years of experience
working in or managing high-containment laboratories. His research
presently focuses on developing and testing new vaccine platforms and
immune treatments against pathogens of high consequences to global
public health. Serving the international community, Dr. Kobinger sits on
several committees.